Is Arcturus Therapeutics Holdings Inc (ARCT) Stock A Better Investment Than Its Rivals?

Canaccord Genuity raised the price target for the Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) stock to “a Buy”. The rating was released on December 13, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as […]